Financial incentive- Does this have impact on outcome of Tuberculosis?

Downloads

Published

2020-06-30

DOI:

https://doi.org/10.47203/IJCH.2020.v32i02.020

Keywords:

RNTCP, Tuberculosis, Financial Incentive

Dimensions Badge

Issue

Vol. 32 No. 2 (2020)

Section

Original Article

License

Copyright (c) 2020 Indian Journal of Community Health

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Authors

  • Bhavesh V Modi GMERS Medical College, Gandhinagar, Gujarat https://orcid.org/0000-0003-0004-6693
  • Bhautik Modi Dr. N. D. Desai Faculty of Medical Sciences and Research, Dharamsinh Desai University, Nadiad https://orcid.org/0000-0002-4227-0354
  • Paresh V Dave Ex-Additional Director (Public Health), Government of Gujarat

Abstract

Background: Although most public services provide tests and TB drugs free of charge worldwide, opportunity costs pose barriers to accessing TB services and treatment. 'Kumar Raajratna Bhimrao Ambedkar Vaidakiya Sahay Yojana (KRBAVSY)' popularly known as Free Medical Aid Scheme is in operation in Gujarat since early 70s for SC and since 1991 for SEBC to provide monetary incentive. Primary objective: Evaluation of utilization and effectiveness of Financial incentives given under Free Medical Aids scheme on RNTCP in Gujarat. Methodology: A retrospective cohort study was undertaken in which all TB patients registered under RNTCP in Gandhinagar district were evaluated for their eligibility for KRBAVSY scheme, and whether eligible patients got benefit or not. Also, treatment outcome of patients were compared. Results: Out of total 1430 patients inquired, 896 (62.7%) patients were found eligible for the scheme, while only 87 (9.7%) patients confirmed that they had got the benefit of scheme. Eligible patients who got benefit under scheme had almost five times higher odds of successful outcome of TB treatment. Conclusion: The TB patients who got benefit of KRBAVSY scheme had significantly better successful treatment outcome in comparison to the TB patients who did not get benefit.

How to Cite

1.
Modi BV, Modi B, Dave PV. Financial incentive- Does this have impact on outcome of Tuberculosis?. Indian J Community Health [Internet]. 2020 Jun. 30 [cited 2023 Mar. 24];32(2):418-22. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/1578

Downloads

Download data is not yet available.

References

WHO | WHO End TB Strategy. Available from: https://www.who.int/tb/End_TB_brochure.pdf?ua=1 . Last accessed on / (12/02/2020)

Bates I, Fenton C, Gruber J, Lalloo D, Medina Lara A, Squire SB, Theobald S, Thomson R, Tolhurst R. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis. 2004 May;4(5):267-77. doi: 10.1016/S1473-3099(04)01002-3. Review. PubMed PMID: 15120343.[PubMed].

WHO. Global TB Report 2013. Available at: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf Last Accessed on: (06/09/2016)

Nutritional care and support for patients with tuberculosis: A review on guidelines issued by WHO. Available at: http://thepharmaresearch.info/ojs/index.php/Tphres/article/download/TPR01001008/pdf_27 . Accessed on (25/06/2017)

World Health Statistics 2012. Available at: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf . Last accessed on (06/092016)

Mauch V, Bonsu F, Gyapong M, Awini E, Suarez P, Marcelino B, Melgen RE, Lönnroth K, Nhung NV, Hoa NB, Klinkenberg E. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents. Int J Tuberc Lung Dis. 2013 Mar;17(3):381-7. doi: 10.5588/ijtld.12.0368. PubMed PMID: 23407227.[PubMed].

KNCV Tuberculosis Foundation, WHO, the Japan Anti-Tuberculosis Association. The Tool to Estimate Patients’ Costs. Available at: http://www.biomedcentral.com/content/supplementary/1471-2458-11-43-S1.PDF Last Accessed on: (06/09/2016)

Worldwide: Incentives for Tuberculosis Diagnosis and Treatment. Available At: http://www.cgdev.org/doc/books/PBI/12_CGD_Eichler_Levine-Ch12.pdf . Accessed on (25/06/2017)

Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, Van den Bergh R, Kumar AM, de Colombani P. Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova?. Public Health Action. 2014 Oct 21;4(Suppl 2):S59-63. doi: 10.5588/pha.14.0047. PubMed PMID: 26393100; PubMed Central PMCID: PMC4547512.[PubMed]

Samuel B, Volkmann T, Cornelius S, Mukhopadhay S, MejoJose, Mitra K, Kumar AM, Oeltmann JE, Parija S, Prabhakaran AO, Moonan PK, Chadha VK. Relationship between Nutritional Support and Tuberculosis Treatment Outcomes in West Bengal, India. J Tuberc Res. 2016 Dec;4(4):213-219. doi: 10.4236/jtr.2016.44023. Epub 2016 Dec 21. PubMed PMID: 28042591; PubMed Central PMCID: PMC5201187.[PubMed].